In a neurodevelopmental model of schizophrenia, the use of minocycline was found to reduce iNOS expression in the prefrontal cortex and caudate-putamen while also preventing morphometric abnormalities in the third ventricle [33]. Here, NOS2 is linked to schizophrenia.